Pfizer is recalling approximately 79,600 cartons of Hospira 4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection. These products are being recalled because particulate matter, identified as glass, was found inside the syringes. These medications are sterile injectables used in hospital and clinical settings; injecting a product contaminated with glass can lead to serious health complications or death.
Injecting a solution containing glass particles can cause inflammation, irritation, or blood clots that may travel to and block blood vessels in the heart, lungs, or brain. No injuries have been reported in connection with this recall at the time of the announcement.
Recall #: D-0233-2024; Quantity: 34000 Cartons
Recall #: D-0234-2024; Quantity: 21200 Cartons
Recall #: D-0235-2024; Quantity: 24400 Cartons
Image 1 - 4.2% sodium bicarbonate injection
Image 2 - 8.4% sodium bicarbonate injection
Image 3 - atropine sulfate injection
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.